372 related articles for article (PubMed ID: 37579835)
1. Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review.
Yadav H; Jaldhi ; Bhardwaj R; Anamika ; Bakshi A; Gupta S; Maurya SK
Life Sci; 2023 Oct; 330():122022. PubMed ID: 37579835
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.
Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK
Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767
[TBL] [Abstract][Full Text] [Related]
3. Modification of the gut microbiome to combat neurodegeneration.
Sasmita AO
Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: Are gut microbes involved?
Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
6. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases.
Loh JS; Mak WQ; Tan LKS; Ng CX; Chan HH; Yeow SH; Foo JB; Ong YS; How CW; Khaw KY
Signal Transduct Target Ther; 2024 Feb; 9(1):37. PubMed ID: 38360862
[TBL] [Abstract][Full Text] [Related]
8. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics.
Peterson CT
J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396
[TBL] [Abstract][Full Text] [Related]
10. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S; Lomis N; Kahouli I; Dia SY; Singh SP; Prakash S
Cell Mol Life Sci; 2017 Oct; 74(20):3769-3787. PubMed ID: 28643167
[TBL] [Abstract][Full Text] [Related]
11. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
12. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
14. Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights.
Taghizadeh Ghassab F; Shamlou Mahmoudi F; Taheri Tinjani R; Emami Meibodi A; Zali MR; Yadegar A
Life Sci; 2024 Aug; 350():122748. PubMed ID: 38843992
[TBL] [Abstract][Full Text] [Related]
15. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases.
Cheng WY; Ho YS; Chang RC
Ageing Res Rev; 2022 Jun; 78():101620. PubMed ID: 35405323
[TBL] [Abstract][Full Text] [Related]
16. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
17. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.
Raval U; Harary JM; Zeng E; Pasinetti GM
Expert Rev Neurother; 2020 Jul; 20(7):673-686. PubMed ID: 32459513
[TBL] [Abstract][Full Text] [Related]
18. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
Ma YY; Li X; Yu JT; Wang YJ
Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
[TBL] [Abstract][Full Text] [Related]
19. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
20. Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders.
Gupta S; Dinesh S; Sharma S
Cent Nerv Syst Agents Med Chem; 2024; 24(1):2-21. PubMed ID: 38265387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
